Masson W, Solís C, Nogueira JP. Semaglutide and Metabolic Dysfunction–Associated Fatty Liver Disease: A Systematic Review. ACTA [Internet]. 2026 Mar. 31 [cited 2026 Nov. 15];56(1):59-70. Available from: https://actaojs.org.ar/ojs/index.php/acta/article/view/591